Associated Papers
Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency.
Schlotawa L et al.
Embo Molecular Medicine, 2023
36789546 (PubMed )
Supplement: EMMM-15-e14837-s010.pdf
Select a paper to view details